Clinical Trials Logo

Clinical Trial Summary

Tertiary lesions responsible of the neurological decline after severe traumatic brain injury (TBI) are partially due to a persistent neuro-inflammation directly modulated by inflammatory mediators during the acute phase and detectable by using both multimodal MRI imaging and biological biomarkers during the acute phase after traumatic brain injury.

The main objective is to identify if the level of IL-1beta in cerebrospinal fluid predict in a reliable and reproducible way, the neuro-radiological evolution evaluated by the comparison of a quantitative MRI performed in post-resuscitation and at one year (quantitative ΔIRM) in traumatic brain injuried patients.

The secondary objectives are:

- To understand the links between the acute and chronic neuro-inflammatory phase in a population of TBI,

- To explore the contribution of the adaptive immune response in the persistent activation of the immune response,

- To Examine the links between persistent neuroinflammation, clinical deterioration and neuroimaging,

- To establish a correlation between the pathology and the physio-pathology of TBI.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03659006
Study type Interventional
Source Assistance Publique - Hôpitaux de Paris
Contact Vincent Degos, PU-PH
Phone 01 42 16 37 61
Email vincent.degos@aphp.fr
Status Recruiting
Phase N/A
Start date October 15, 2018
Completion date July 30, 2020

See also
  Status Clinical Trial Phase
Completed NCT04383405 - Aquatic Sequential Preparatory Approach and Severe Traumatic Brain Injury N/A
Completed NCT00974259 - Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI) Phase 2
Completed NCT04664699 - Randomized Control Trial to Compare Standard Monitoring and Plethysmographic Variability Index-Guided Fluid Therapy In 64 Severe Traumatic Brain Injury Patients, Aged 18 to 60 Years Old Undergoing Emergency Craniotomies N/A
Not yet recruiting NCT06363474 - Cisternostomy Vs Decompressive Craniectomy for Severe Traumatic Brain Injury N/A
Recruiting NCT05566431 - Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics N/A
Not yet recruiting NCT06429657 - Ketamine for Sedation in Severe Traumatic Brain Injury Phase 4
Not yet recruiting NCT05889650 - External Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical Trial N/A
Completed NCT04415580 - Vestibular Rehabilitation and Severe Traumatic Brain Injury N/A
Completed NCT00890604 - Outcomes Associated With Application of a Normothermia Protocol in Patients With Severe Neurological Insult and Fever N/A
Recruiting NCT00788723 - Cortical Excitability in Patients With Severe Brain Injury N/A
Completed NCT00676104 - Discrete Hypothermia in the Management of Traumatic Brain Injury Phase 3
Completed NCT04077411 - Approaches and Decisions for Acute Pediatric TBI Trial
Completed NCT04323150 - The Effect of Closed Suction System on the Incidence of Ventilator-associated Pneumonia. N/A
Completed NCT00930202 - Study of the Safety and Efficacy of Conivaptan (Vaprisol®) to Raise Serum Sodium Levels in Patients With Severe Traumatic Brain Injury Phase 1
Recruiting NCT00489892 - Efficacy of Pharmacological Treatment of Working Memory Impairment After Traumatic Brain Injury: Evaluation With fMRI N/A
Recruiting NCT04597879 - Impact of Severe Brain Injury on Neuro-vascular and Endothelial Regulation of Peripheral Microcirculation.
Completed NCT06306950 - Prioritization of Cerebral Deoxygenation in Severe Traumatic Brain Injury and Mortality Benefit. N/A